Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sudafed Blocked Nose 0.1% spray
1202020P0BJAAAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 311 |
|
Sudafed Congestion Relief 0.1% nasal spray
1202020P0BJACAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 8 |
|
Sudafed Sinus-Ease 0.1% nasal spray
1202020P0BJAEAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 3 |
|
Sudafed Mucus Relief 0.1% nasal spray
1202020P0BJABAC
|
Sudafed (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.